Scinai (SCNI) news
Recent news
Scinai reports first half 2026 corporate highlights and results with spotlight on growing CDMO momentum
AInvest Wire · 7d agoScinai strengthens CDMO leadership with appointment of Eran Kuratz as head of supply chain and business process administration
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) has announced the appointment of Eran Kuratz as head of supply chain and business process administration for its wholly owned subsidiary, Scinai Biopharma Services Ltd. This move is part of the company’s ongoing efforts to enhance operational efficiency…
AInvest Wire · Aug 10, 2026Scinai Immunotherapeutics Q1 net income USD 3.6 million
AInvest Wire · Jun 10, 2026Scinai reports first quarter 2026 financial results and provides corporate update highlighting expansion of CDMO platform and advancement of strategic growth initiatives
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) reported its first quarter 2026 financial results and provided a corporate update highlighting the expansion of its CDMO platform and the advancement of strategic growth initiatives. The company has completed a strategic reorganization to establish a…
AInvest Wire · Jun 10, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.